Institutional shares held 36.6 Million
82.6K calls
1.1K puts
Total value of holdings $600M
$1.35M calls
$18K puts
Market Cap $684M
42,283,700 Shares Out.
Institutional ownership 86.51%
# of Institutions 181


Latest Institutional Activity in AXGN

Top Purchases

Q1 2025
Assenagon Asset Management S.A. Shares Held: 1M ($16.2M)
Q1 2025
Advisor Resource Council Shares Held: 121K ($1.96M)
Q1 2025
High Mark Wealth Management LLC Shares Held: 35.7K ($578K)
Q1 2025
Sg Americas Securities, LLC Shares Held: 38K ($615K)
Q1 2025
Calamos Advisors LLC Shares Held: 40.8K ($660K)

Top Sells

Q1 2025
Exchange Traded Concepts, LLC Shares Held: 51.2K ($829K)
Q1 2025
Gamma Investing LLC Shares Held: 308 ($4.98K)
Q1 2025
Sentry Investment Management LLC Shares Held: 12.5K ($201K)
Q1 2025
Principal Financial Group Inc Shares Held: 15.8K ($256K)
Q1 2025
First Horizon Advisors, Inc. Shares Held: 1.03K ($16.6K)

About AXGN

AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.


Insider Transactions at AXGN

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
273K Shares
From 21 Insiders
Grant, award, or other acquisition 95.6K shares
Exercise of conversion of derivative security 177K shares
Sell / Disposition
80K Shares
From 6 Insiders
Payment of exercise price or tax liability 59.9K shares
Open market or private sale 20.1K shares

Track Institutional and Insider Activities on AXGN

Follow Axogen, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXGN shares.

Notify only if

Insider Trading

Get notified when an Axogen, Inc. insider buys or sells AXGN shares.

Notify only if

News

Receive news related to Axogen, Inc.

Track Activities on AXGN